Experienced in Acute Megakaryoblastic Leukemia

Min J. Peng

2Department Of Oncology, No. 238 Jiefang Road, 
Wuhan, CN 
Experienced in Acute Megakaryoblastic Leukemia
2Department Of Oncology, No. 238 Jiefang Road, 
Wuhan, CN 
OverviewLocationsClinical Research

Overview

Min Peng practices in Wuhan, China. Peng is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. Their top areas of expertise are Squamous Cell Lung Carcinoma, Lung Cancer, EGFR Positive Lung Cancer, and Pneumonia.

Their clinical research consists of co-authoring 62 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Acute Megakaryoblastic Leukemia.

Locations

2Department Of Oncology, No. 238 Jiefang Road, Wuhan, 430060, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Phase 1, Open-label, Two Routes IV and Intra-hepatic Artery Dose-escalation Clinical Study to Evaluate the Safety and Efficacy of ET1402L1-CAR T- Cells in AFP Expressing Hepatocellular Carcinoma (HCC)
Phase 1, Open-label, Two Routes IV and Intra-hepatic Artery Dose-escalation Clinical Study to Evaluate the Safety and Efficacy of ET1402L1-CAR T- Cells in AFP Expressing Hepatocellular Carcinoma (HCC)
Enrollment Status: Terminated
Publish Date: July 01, 2019
Intervention Type: Biological
Study Phase: Phase 1

62 Total Publications

NOX4 modulates breast cancer progression through cancer cell metabolic reprogramming and CD8+ T cell antitumor activity.
NOX4 modulates breast cancer progression through cancer cell metabolic reprogramming and CD8+ T cell antitumor activity.
Journal: Frontiers in immunology
Published: November 26, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Peng's expertise for a condition
ConditionClose
        View All 14 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile